Q2 EPS Estimate for Hercules Capital Decreased by Analyst

Hercules Capital, Inc. (NYSE:HTGC) – Research analysts at Zacks Research dropped their Q2 2025 earnings per share estimates for Hercules Capital in a report issued on Thursday, May 22nd. Zacks Research analyst R. Department now anticipates that the financial services provider will post earnings per share of $0.47 for the quarter, down from their prior estimate of $0.48. The consensus estimate for Hercules Capital’s current full-year earnings is $1.96 per share. Zacks Research also issued estimates for Hercules Capital’s Q3 2025 earnings at $0.48 EPS, Q2 2026 earnings at $0.49 EPS and Q1 2027 earnings at $0.51 EPS.

Hercules Capital (NYSE:HTGC) last posted its quarterly earnings results on Thursday, May 1st. The financial services provider reported $0.45 EPS for the quarter, missing analysts’ consensus estimates of $0.46 by ($0.01). Hercules Capital had a return on equity of 17.19% and a net margin of 53.28%. The business had revenue of $102.10 million for the quarter, compared to the consensus estimate of $125.43 million. During the same quarter in the previous year, the business posted $0.50 EPS. The company’s revenue for the quarter was down 1.6% on a year-over-year basis.

Other equities analysts have also recently issued research reports about the company. Compass Point lifted their price target on Hercules Capital from $18.25 to $20.00 and gave the stock a “neutral” rating in a report on Wednesday, February 19th. UBS Group cut their price objective on shares of Hercules Capital from $20.00 to $18.00 and set a “neutral” rating for the company in a research report on Thursday, April 17th. Piper Sandler cut their price objective on shares of Hercules Capital from $23.00 to $20.00 and set an “overweight” rating for the company in a research report on Tuesday, April 8th. Keefe, Bruyette & Woods cut their price objective on shares of Hercules Capital from $21.50 to $20.50 and set an “outperform” rating for the company in a research report on Tuesday, April 8th. Finally, JMP Securities restated a “market outperform” rating and set a $22.00 price objective on shares of Hercules Capital in a research report on Friday, February 14th. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat, Hercules Capital has a consensus rating of “Moderate Buy” and an average target price of $19.92.

Hercules Capital Trading Up 0.5%

Hercules Capital stock opened at $17.40 on Monday. Hercules Capital has a 52 week low of $15.65 and a 52 week high of $22.04. The company has a debt-to-equity ratio of 0.89, a quick ratio of 2.72 and a current ratio of 2.72. The stock has a market capitalization of $3.05 billion, a P/E ratio of 10.81 and a beta of 0.97. The stock has a 50-day simple moving average of $17.87 and a 200 day simple moving average of $19.19.

Institutional Investors Weigh In On Hercules Capital

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Rockefeller Capital Management L.P. raised its position in shares of Hercules Capital by 0.4% in the fourth quarter. Rockefeller Capital Management L.P. now owns 138,364 shares of the financial services provider’s stock valued at $2,780,000 after buying an additional 496 shares in the last quarter. Naples Global Advisors LLC raised its position in shares of Hercules Capital by 1.0% in the fourth quarter. Naples Global Advisors LLC now owns 62,259 shares of the financial services provider’s stock valued at $1,251,000 after buying an additional 600 shares in the last quarter. Wealth Enhancement Advisory Services LLC increased its stake in Hercules Capital by 2.0% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 32,832 shares of the financial services provider’s stock valued at $631,000 after acquiring an additional 628 shares during the last quarter. Sand Hill Global Advisors LLC increased its stake in Hercules Capital by 2.5% in the fourth quarter. Sand Hill Global Advisors LLC now owns 27,417 shares of the financial services provider’s stock valued at $551,000 after acquiring an additional 665 shares during the last quarter. Finally, Graypoint LLC increased its stake in Hercules Capital by 0.4% in the first quarter. Graypoint LLC now owns 165,597 shares of the financial services provider’s stock valued at $3,181,000 after acquiring an additional 694 shares during the last quarter. 19.69% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other Hercules Capital news, Director Nikos Theodosopoulos purchased 5,999 shares of the company’s stock in a transaction dated Thursday, May 8th. The stock was bought at an average cost of $17.49 per share, for a total transaction of $104,922.51. Following the completion of the transaction, the director now owns 11,960 shares in the company, valued at approximately $209,180.40. This represents a 100.64% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this link. 1.90% of the stock is owned by company insiders.

Hercules Capital Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, May 20th. Shareholders of record on Tuesday, May 13th were given a dividend of $0.40 per share. The ex-dividend date was Tuesday, May 13th. This represents a $1.60 annualized dividend and a yield of 9.20%. Hercules Capital’s dividend payout ratio (DPR) is presently 120.30%.

About Hercules Capital

Hercules Capital, Inc is a business development company. The firm specializing in providing venture debt, debt, senior secured loans, and growth capital to privately held venture capital-backed companies at all stages of development from startups to expansion stage including select publicly listed companies and select special opportunity lower middle market companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies.